Healthcare

Galmed (NASDAQ: GLMD) Signed Term Sheet for the Development of Novel Semaglutide Sublingual Formulation

The proprietary Self-Emulsifying Drug Delivery System (SEDDS) formulation in form of orally dispersible films allows absorption of sublingually administrated peptides such as GLP-1 (Semaglutide, Liraglutide etc.). The new formulation is expected to offer alternatives to both approved […]

Healthcare

Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the LIBERTY® Endovascular Robotic System

Successful robotic navigation was achieved in every case and met the primary endpoint of the study LIBERTY® showed a 92% reduction in radiation exposure with no adverse events reported HINGHAM, Mass., April 09, 2025 — Microbot Medical […]

Healthcare

AI/ML Innovations (OTC: AIMLF) Subsidiary Chosen as the Digital Technology Provider for an International Clinical Study Funded by European Commission

Highlights: AI/ML’s subsidiary, Tech2heal, expands its global footprint with second clinical trial contract – conducted jointly by French and Italian University Hospitals. The clinical trial is funded by a European Commission fund. The study includes […]

Healthcare

AI/ML Innovations (OTC: AIMLF) Subsidiary Receives Funding Grant for Its Participation in Europe’s Largest Study for the Prevention of Loss of Autonomy in the Elderly

Highlights: The clinical study, led by the University Hospital of Nice, France involves 30,000 patients. AI/ML Innovations’ subsidiary, Tech2Heal, has been chosen to provide the “technological backbone” for the study. Tech2heal has been awarded a […]

Healthcare

Nova Mentis (OTC: NMLSF) to Enter mRNA AI Diagnostics Business

Vancouver, British Columbia–April 26, 2023 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory […]

Healthcare

Nova Mentis (OTC: NMLSF) Begins Recruitment in First-of-its-Kind Health Canada Psilocybin Trial

Vancouver, British Columbia– – April 18, 2023- Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for […]

Healthcare

Nova Mentis (OTC: NMLSF) Receives Institutional Review Board Approval to Commence Psilocybin Clinical Trial

Vancouver, British Columbia– April 11, 2023 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for […]

Healthcare

AI/ML Innovations (OTC: AIMLF) Introduces “Health Coach” – a Personalized AI-powered Health Advisor

Health Coach has functionality similar to ChatGPT, but is designed to monitor and manage the users health. Health Coach provides conversational personal health goal setting and care recommendations by directly accessing and utilizing a user’s […]

Healthcare

Nova Mentis (OTC: NMLSF) Provides Corporate Update and 2023 Outlook

Vancouver, British Columbia— April 5, 2023- Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory […]

Healthcare

Increasing Autism Rates Put Spotlight on Potential for Nova Mentis (OTC: NMLSF) Novel Psilocybin Therapeutics

Vancouver, British Columbia–March 29, 2023 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory […]

Healthcare

AI/ML Innovations’ (OTC: AIMLF) (OTC: AIML) Tech2Heal Chosen for Europe’s Largest Study for the Prevention of Loss of Autonomy in the Elderly

The Study, Led by the University Hospital of Nice, France Involves 30,000 Patients Tech2Heal’s Platform has been chosen as the technological backbone for the Study 3.4million Europeans live in assisted-care facilities, and 101million are 65 […]

Healthcare

AI/ML Innovations (OTC: AIMLF) Health Gauge Concludes Successful Blood Pressure Validation Study on its AI-Powered Health Monitoring Solution

TORONTO, ON /March 6, 2023 / AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to report that its wholly owned subsidiary, Health […]

Healthcare

AI/ML Innovations (OTC: AIMLF) Tech2Heal Wins Prestigious Innovation Grand Prize Award

TORONTO, ON / February 2, 2023 / AI/ML Innovations Inc. (“AIML”) (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that its minority-owned […]